FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:829-831 March 19, 1998 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

The history of hemolytic disease of the newborn dates to the 1600s, when a French midwife described the birth of twins, one of whom had fatal hydrops fetalis and the other of whom was initially icteric and later died. Centuries have passed, yet morbidity and mortality remain high despite a dramatic increase in our understanding of the pathogenesis and treatment of this condition.

Hemolytic disease of the newborn occurs when fetal red cells cross the placenta and the mother is immunized with a fetal red-cell antigen that is not present on her red cells. The resulting immune response triggers the . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.